Amicus Therapeutics(FOLD.US) Officer Sells US$14,002.94 in Common Stock

$Amicus Therapeutics(FOLD.US)$ Officer Campbell Bradley L sold 1,400 shares of common stock on Jul 1, 2024 at an average price of $10.0021 for a total value of $14,002.94.Source: Announcement What is

Futu NewsJul 4 05:04

Does Amicus Therapeutics (NASDAQ:FOLD) Have A Healthy Balance Sheet?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will

Simply Wall StJun 30 22:10

Investors in Amicus Therapeutics (NASDAQ:FOLD) From a Year Ago Are Still Down 19%, Even After 3.9% Gain This Past Week

Yahoo FinanceJun 7 23:07

Amicus Therapeutics(FOLD.US) Officer Sells US$75,000 in Common Stock

$Amicus Therapeutics(FOLD.US)$ Officer Campbell Bradley L sold 7,500 shares of common stock on Jun 3, 2024 at an average price of $10 for a total value of $75,000.Source: Announcement What is statemen

Futu NewsJun 6 05:16

Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

PRINCETON, N.J., June 05, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (NASDAQ:FOLD) today announced that management will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference in

GlobeNewswireJun 5 19:00

Amicus Therapeutics Receives Prix Galien U.K. Award for Pombiliti (Cipaglucosidase Alfa) + Opfolda (Miglustat) as Best Pharmaceutical Product

PRINCETON, N.J., June 04, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (NASDAQ:FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for rare diseases, today

GlobeNewswireJun 4 19:00